LifeStance Health Group, Inc.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.42B | $1.25B | $1.06B | $859.5M | $667.5M | — | $212.5M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | — | $382.2M | $363.1M | $410.8M | $378.0M | $433.7M | — | $41.1M |
| Operating Income | — | $24.1M | $-31.6M | $-189.1M | $-210.2M | $-286.4M | — | $15.2M |
| Operating Margin | — | 1.7% | -2.5% | -17.9% | -24.5% | -42.9% | — | 7.2% |
| Interest Expense | — | $11.7M | $26.5M | $21.2M | $19.9M | $38.9M | — | $5.4M |
| Pretax Income | — | $12.4M | $-57.6M | $-206.6M | $-232.7M | $-333.1M | — | $7.9M |
| Income Tax Expense | — | $2.7M | $-170.0K | $-20.3M | $-17.2M | $-25.9M | — | $2.2M |
| Net Income | — | $9.7M | $-57.4M | $-186.3M | $-215.6M | $-307.2M | — | $5.7M |
| Net Margin | — | 0.7% | -4.6% | -17.6% | -25.1% | -46.0% | — | 2.7% |
| EPS (Basic) | — | $0.03 | $-0.15 | $-0.51 | $-0.61 | $0.00 | — | — |
| EPS (Diluted) | — | $0.02 | $-0.15 | $-0.51 | $-0.61 | $0.00 | — | — |
| Shares Outstanding (Basic) | 389.8M | 386.0M | 379.1M | 367.5M | 355.3M | 355.4M | 0 | — |
| Shares Outstanding (Diluted) | 389.8M | 391.1M | 379.1M | 367.5M | 355.3M | 355.4M | 0 | — |
| Dividends Per Share | — | — | — | — | — | — | — | — |